Literature DB >> 12062363

Characterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome.

Kenshi Hayashi1, Masami Shimizu, Hidekazu Ino, Masato Yamaguchi, Hiroshi Mabuchi, Naoto Hoshi, Haruhiro Higashida.   

Abstract

OBJECTIVE: In a 32-year-old woman with marked QT prolongation (QTc=0.61 s) and repeated episodes of syncope, we identified a single pertinent base substitution (G to A at 1909) in HERG by genetic analysis. This novel missense mutation is predicted to cause an amino acid substitution of lysine for glutamic acid at position 637 (E637K) in the pore-S6 loop. Therefore, we investigated the role of a glutamic acid at the vicinity of the pore in HERG channels by mutating it to a lysine.
METHODS: We characterized the electrophysiological properties of the E637K mutation using a Xenopus oocyte heterologous expression system.
RESULTS: Injection of the E637K mutant cRNA alone into Xenopus oocytes did not result in any expression of detectable currents. Coexpression of wild-type (WT) and E637K (E637K/WT) elicited only about 30% of the control peak tail current that was expected from expression of WT alone. Kinetic analyses revealed that E637K/WT decelerated the rate of channel activation and enhanced steady-state inactivation. Furthermore, the reversal potentials at low concentrations of K+ showed a positive shift in oocytes injected with E637K/WT compared with WT alone.
CONCLUSIONS: These results indicated that the E637K mutation causes apparent dominant negative suppression of WT HERG channel function and suggest that E637 at the Pore-S6 is a crucial component of the activation and inactivation gate of HERG channels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062363     DOI: 10.1016/s0008-6363(02)00240-7

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  Gene therapy for inherited arrhythmias.

Authors:  Vassilios J Bezzerides; Maksymilian Prondzynski; Lucie Carrier; William T Pu
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

2.  RNA interference-based therapeutics for inherited long QT syndrome.

Authors:  Guoliang Li; Shuting Ma; Chaofeng Sun
Journal:  Exp Ther Med       Date:  2015-06-12       Impact factor: 2.447

3.  Effect of S5P alpha-helix charge mutants on inactivation of hERG K+ channels.

Authors:  C E Clarke; A P Hill; J Zhao; M Kondo; R N Subbiah; T J Campbell; J I Vandenberg
Journal:  J Physiol       Date:  2006-03-23       Impact factor: 5.182

4.  Trafficking-deficient G572R-hERG and E637K-hERG activate stress and clearance pathways in endoplasmic reticulum.

Authors:  Ying Wang; Xiaoyan Huang; Jianqing Zhou; Xi Yang; Di Li; Haiyan Mao; Huan Huan Sun; Ningsheng Liu; Jiangfang Lian
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

5.  Voltage-gated sodium channels assemble and gate as dimers.

Authors:  Jérôme Clatot; Malcolm Hoshi; Xiaoping Wan; Haiyan Liu; Ankur Jain; Krekwit Shinlapawittayatorn; Céline Marionneau; Eckhard Ficker; Taekjip Ha; Isabelle Deschênes
Journal:  Nat Commun       Date:  2017-12-12       Impact factor: 14.919

6.  Pharmacologic Approach to Defective Protein Trafficking in the E637K-hERG Mutant with PD-118057 and Thapsigargin.

Authors:  Haiyan Mao; Xiaoli Lu; Justin Michael Karush; Xiaoyan Huang; Xi Yang; Yanna Ba; Ying Wang; Ningsheng Liu; Jianqing Zhou; Jiangfang Lian
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.